Filtering options
ADC
Advanced Analytics
Advanced Therapies
Antibody-Drug Conjugates
Biologics
Biometrics
Biopharma
BioRegion
Biosimilars
Biostatistics
Biotech
Cardiology
CDD
CDMO
Cell & Gene Therapy (CGT)
Clinical
Clinical Operations
Clinical Trials
CMC
Co-Design
Complex Innovative Design
CRO
Crowdfunding
Data Science
Decentralized Clinical Trials
Dermatology
Diabetes
Diagnostics
Digital Health
Digital Therapeutics
Digital Transformation
Diversity
Drug Delivery
Drug Development
Due Diligence
eCOA
Environmental Policy
EU
European Medicines Agency
France
Funding
Genomic Testing
Health Economics
Health Policy
Healthcare Technology
HEOR
Hospitals
Hybrid Clinical Trials
In-Vitro Diagnostic Regulation
Innovation
Investor Relations
ISE/ISS
Italy
IVDR
Life Sciences
Lifecycle Optimization
Lupus
M&A
Market Access
Medical Devices
Medical Robotics
MedTech
Mobile Tech
Myasthenia Gravis (MG)
Nuclear Medicine
Oncology
Orphan Drug
Orthopedic
Outcomes Research
Outsourcing Clinical Trials
Patient Advocacy
Patient Centricity
Patient Engagement
Patient-Enabled Innovation
Pharma
Press Release
Pricing
Product Development
Radioligand Therapies (RLTs)
Radiopharmaceuticals
Rare Disease
Real-World Evidence (RWE)
Registry-based studies
Regulatory
Research & Development
Research and Development
Robotic-Assisted Surgery (RAS)
RWE Decision Alert
Spain
Startups
Strategic Expansion
Sustainability
Therapeutics
Transaction Advisory
UK
USA
Vaccines
Value-Based Contracts
Wound Healing
All
Latest from Alira Health
Value-Based Healthcare: Frequently Asked Questions
Explore expert answers to key questions on VBHC from the Global Payer Forum. Learn how to overcome barriers and drive implementation.
Tangible Ways Patient Insights Accelerate Access and Product Launch
This article explores how leveraging patient insights can help companies overcome market access barriers and improve their chances of success.
Heart Failure Medical Devices Market Landscape in 2025
Explore the forces shaping heart failure medical devices, the emerging technologies driving innovation, and the key challenges on the road ahead.
Pharma Company Defines Advocacy Strategy Through Data-Driven Patient Association Mapping
Alira Health mapped 253 CVRM patient advocacy groups across 11 countries, delivering a data-driven strategy to optimize partnerships, advocacy efforts, and differentiation.
Rare Disease Pharma Maps Rare Cholestatic Liver Disease Journey for Targeted Patient Engagement
A global pharmaceutical company specializing in rare diseases, oncology, and neuroscience sought to analyze the patient journey for progressive familial intrahepatic cholestasis (PFIC).
Family Office Optimizes Biosimilar Investments Through Strategic Capital Market Transaction
A client reached out to appropriately value two biosimilar assets, facilitate discussions with its management, and coordinate the capital market transaction as an asset-contribution in kind.
2025 SNMMI Annual Meeting
Connect with our delegates onsite to discover how we can support you in developing nuclear medicine solutions.
MEET2WIN 2025
Discover how we can help you accelerate innovation and deliver tomorrow’s standard of care for oncology patients.
The Medtech Forum 2025
Connect with our experts to learn how we can help accelerate patient access to your innovations.
Alira Health Oversees the Digital Development of Gustave Roussy’s Project Interception to Advance Cancer Prevention
Alira Health, a global healthcare advisory and technology company, is proud to collaborate as a commercial partner with the digital development of Project Interception, a pioneering(...)
Alira Health Launches SpherePX™, a Next-Generation Technology Platform to Advance Real-World Evidence
Alira Health announces the global launch of its innovative technology platform SpherePX, designed to drive real-world evidence (RWE) collection and elevate patient engagement and retention.(...)
Alira Health Launches the Global Payer Forum 2025 in Partnership with UPF Barcelona School of Management, NEWDIGS at Tufts Medical Center, and the University College of London
Alira Health is excited to announce the second year of the Global Payer Forum, a landmark educational initiative in partnership with distinguished academic institutions, UPF Barcelona(...)
Nuclear Medicine in 2024: A Year of Breakthroughs and Challenges
Nuclear medicine is entering a game-changing era. Breakthroughs in radiopharmaceuticals, cutting-edge clinical advancements, and surging investments are propelling the field forward.
Biologics and Advanced Therapies Contract Manufacturing: Public Market Update
Gain a comprehensive analysis of publicly traded companies in the sector, including the performance and strategies of global leaders, regional specialists, and niche innovators, providing(...)
The 2024 Global Antibody-Drug Conjugates Report
Gain comprehensive insights into the ADC market with our 2024 Global Antibody-Drug Conjugates Report. This in-depth analysis covers market trends, clinical development challenges, innovation(...)
Randomized Controlled Trial Evidence of Cost-Effectiveness of a Multifaceted AKI Intervention Approach
Acute kidney injury (AKI) is linked to elevated healthcare usage and greater expenses. The Tackling AKI study, a pragmatic, multicenter, stepped-wedge cluster randomized trial, showcased(...)
Best Practices for Health Technology Assessment of Robotic Assisted Surgery
An expert panel developed seven best-practice recommendations for evaluating Robotics Assisted Surgical systems and here are the results.
Therapeutic IgG-Like Bispecific Antibodies: Modular Versatility and Manufacturing Challenges
Our experts conducted a deep evaluation of IgG-like bsAbs including general advantages and disadvantages compared with MAbs and more.
Subscribe to our newsletter for the latest news, events, and thought leadership